Related Experiment Video
Updated: Apr 12, 2026

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
Published on: February 20, 2021
A prospective treatment for sepsis
Mohammad Rashid Shahidi Bonjar1, Leyla Shahidi Bonjar2
1School of Dentistry, Kerman University of Medical Sciences, Kerman, Iran.
This paper introduces a novel extracorporeal treatment using a bacterial polyvalent antibody-column (BPVAC) to remove bacterial toxins and antigens from sepsis patients, offering a new auxiliary therapy option.
Area of Science:
- Medical Engineering
- Nanotechnology
- Immunology
- Biochemistry
- Emergency Medicine
- Internal Medicine
- Infectious Diseases
Background:
- Sepsis remains a life-threatening condition with limited treatment options.
- Current treatments may have side effects or be ineffective against antibiotic-resistant bacteria.
- There is a need for innovative auxiliary therapies to improve sepsis patient outcomes.
Purpose of the Study:
- To propose and describe a novel prospective auxiliary treatment for sepsis.
- To detail the mechanism of an extracorporeal device for removing bacterial antigens and toxins (BATs).
- To highlight the potential advantages and applications of this new therapeutic approach.
Main Methods:
- Development of a bacterial polyvalent antibody-column (BPVAC) utilizing carbon nanotubes.
- BPVAC selectively traps a wide spectrum of BATs from patient blood in an extracorporeal circuit.
- Detoxified blood is returned to the patient aseptically, without dialysis.
Main Results:
- The BPVAC acts as a biological filter, immobilizing harmful BATs.
- Offers urgent neutralization of BATs, parallel use with conventional treatments, and potential to minimize side effects.
- Effective for antibiotic-resistant bacteria and BATs, with potential for universal application.
Conclusions:
- The BPVAC presents a promising, targeted auxiliary treatment for sepsis.
- Further animal evaluations and human clinical trials are necessary for optimization and validation.
- Interdisciplinary collaboration and investment are crucial for advancing this technology.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Endocarditis IV: Nursing Management
Endocarditis III: Medical Management
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...

